NO20063958L - HIV integrase inhibitorer - Google Patents
HIV integrase inhibitorerInfo
- Publication number
- NO20063958L NO20063958L NO20063958A NO20063958A NO20063958L NO 20063958 L NO20063958 L NO 20063958L NO 20063958 A NO20063958 A NO 20063958A NO 20063958 A NO20063958 A NO 20063958A NO 20063958 L NO20063958 L NO 20063958L
- Authority
- NO
- Norway
- Prior art keywords
- integrase inhibitors
- hiv integrase
- hiv
- treatment
- aids
- Prior art date
Links
- 229940099797 HIV integrase inhibitor Drugs 0.000 title abstract 2
- 239000003084 hiv integrase inhibitor Substances 0.000 title abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Foreliggende oppfinnelse omfatter forbindelser som er HIV integrase inhibitorer og som derfor er anvendelige ved hemning av HIV replikasjon, forebygging og/eller behandling av infeksjon ved HIV og ved behandling av AIDS og/eller ARC.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54367004P | 2004-02-11 | 2004-02-11 | |
| PCT/US2005/004085 WO2005077050A2 (en) | 2004-02-11 | 2005-02-10 | Hiv integrase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20063958L true NO20063958L (no) | 2006-09-22 |
Family
ID=34860447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20063958A NO20063958L (no) | 2004-02-11 | 2006-09-05 | HIV integrase inhibitorer |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US8691991B2 (no) |
| EP (1) | EP1720856B1 (no) |
| JP (1) | JP4859676B2 (no) |
| KR (1) | KR20070002006A (no) |
| CN (1) | CN1976915A (no) |
| AU (1) | AU2005211733A1 (no) |
| BR (1) | BRPI0507628A (no) |
| CA (1) | CA2555176A1 (no) |
| ES (1) | ES2433477T3 (no) |
| IL (1) | IL177189A0 (no) |
| MA (1) | MA28358A1 (no) |
| MX (1) | MXPA06009132A (no) |
| NO (1) | NO20063958L (no) |
| RU (1) | RU2006128848A (no) |
| WO (1) | WO2005077050A2 (no) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2433477T3 (es) | 2004-02-11 | 2013-12-11 | Glaxosmithkline Llc | Inhibidores de integrasa de VIH |
| MX302718B (es) | 2005-04-28 | 2012-08-27 | Smithkline Beecham Corp | Derivado de carbamoilpiridona policiclico que tiene actividad inhibidora de la integrasa de hiv. |
| US20080194523A1 (en) * | 2005-08-04 | 2008-08-14 | Smithkline Beecham Corporation | Hiv Integrase Inhibitors |
| US20080214527A1 (en) * | 2005-08-04 | 2008-09-04 | Takashi Kawasuji | Hiv Integrase Inhibitors |
| EP1909578A4 (en) * | 2005-08-04 | 2010-07-14 | Glaxosmithkline Llc | INHIBITORS OF HIV INTEGRASE |
| EP1910356A4 (en) * | 2005-08-04 | 2009-10-21 | Smithkline Beecham Corp | HIV integrase |
| PE20071020A1 (es) * | 2006-03-07 | 2007-12-11 | Smithkline Beecham Corp | Compuestos derivados de glicina n-sustituidos como inhibidores de prolil hidroxilasa |
| KR101409261B1 (ko) * | 2006-05-26 | 2014-06-18 | 다이쇼 세이야꾸 가부시끼가이샤 | 신규의 복소환 화합물 또는 그 염 및 그 중간체 |
| EP1956016A1 (en) * | 2006-12-15 | 2008-08-13 | Bayer Schering Pharma Aktiengesellschaft | Bicyclic acyltryptophanols |
| CA2672656C (en) | 2006-12-18 | 2012-03-20 | Amgen Inc. | Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| US8048892B2 (en) | 2006-12-18 | 2011-11-01 | Amgen Inc. | Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| JP2010524935A (ja) * | 2007-04-18 | 2010-07-22 | メルク・シャープ・エンド・ドーム・コーポレイション | 新規1,8−ナフチリジン化合物 |
| AU2008241483B2 (en) | 2007-04-18 | 2011-03-24 | Amgen Inc. | Quinolones and azaquinolones that inhibit prolyl hydroxylase |
| WO2008130508A1 (en) | 2007-04-18 | 2008-10-30 | Amgen Inc. | Indanone derivatives that inhibit prolyl hydroxylase |
| WO2008137060A1 (en) | 2007-05-04 | 2008-11-13 | Amgen Inc. | Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity |
| CA2685219C (en) | 2007-05-04 | 2012-06-19 | Amgen Inc. | Diazaquinolones that inhibit prolyl hydroxylase activity |
| WO2010011818A1 (en) * | 2008-07-25 | 2010-01-28 | Smithkline Beecham Corporation | Chemical compounds |
| WO2010011819A1 (en) * | 2008-07-25 | 2010-01-28 | Smithkline Beecham Corporation | Chemical compounds |
| US8283366B2 (en) * | 2010-01-22 | 2012-10-09 | Ambrilia Biopharma, Inc. | Derivatives of pyridoxine for inhibiting HIV integrase |
| LT3494972T (lt) | 2010-01-27 | 2024-03-12 | Viiv Healthcare Company | Dolutegraviro ir lamivudino kompozicija živ infekcijai gydyti |
| US20110223131A1 (en) * | 2010-02-24 | 2011-09-15 | Gilead Sciences, Inc. | Antiviral compounds |
| RU2605549C2 (ru) * | 2010-04-02 | 2016-12-20 | Синомикс, Инк. | Производные 3-карбокси-4-аминохинолина, полезные как модификаторы сладкого вкуса |
| CN103153959A (zh) | 2010-10-14 | 2013-06-12 | 伊姆纳尔公司 | 作为AhR活化剂的1,2-二氢-4-羟基-2-氧代-喹啉-3-甲酰苯胺类 |
| US9359300B2 (en) | 2010-12-06 | 2016-06-07 | Confluence Life Sciences, Inc. | Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds |
| ES2873029T3 (es) | 2010-12-06 | 2021-11-03 | Aclaris Therapeutics Inc | Compuestos de piridinona-piridinilo sustituidos |
| CN103608345A (zh) | 2011-04-26 | 2014-02-26 | 盐野义制药株式会社 | 噁嗪衍生物和含有该噁嗪衍生物的bace1抑制剂 |
| BR112014003285B1 (pt) | 2011-08-12 | 2020-01-14 | Firmenich Incorporated | modificador de sabor doce |
| PT3067358T (pt) | 2012-12-21 | 2019-11-18 | Gilead Sciences Inc | Compostos carbamoílpiridona policíclicos e sua utilização farmacêutica |
| HRP20210813T1 (hr) | 2013-06-07 | 2021-06-25 | Aclaris Therapeutics, Inc. | Piridinonpiridinilni spojevi supstituirani s metil/fluorpiridinilmetoksi i piridinonpiridinilni spojevi supstituirani s fluorpirimidinilmetoksi |
| WO2016073251A1 (en) | 2014-11-07 | 2016-05-12 | Senomyx, Inc. | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers |
| CN105348282B (zh) * | 2015-12-02 | 2018-06-29 | 北京工业大学 | 一种hiv-1整合酶抑制剂化合物及其制备方法和应用 |
| CN115666566A (zh) | 2020-03-27 | 2023-01-31 | 阿克拉瑞斯治疗股份有限公司 | 用于免疫病况的治疗的mk2途径抑制剂的口服组合物 |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK4322003A3 (en) | 2000-10-12 | 2003-09-11 | Merck & Co Inc | Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| ATE364385T1 (de) | 2000-10-12 | 2007-07-15 | Merck & Co Inc | Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer |
| AU2002230392A1 (en) | 2000-10-12 | 2002-05-15 | Merck & Co., Inc. | AZA-and polyaza-naphthalenyl ketones useful as HIV integrase inhibitors |
| DE60124577T2 (de) | 2000-10-12 | 2007-09-27 | Merck & Co., Inc. | Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer |
| PL365027A1 (en) | 2001-03-01 | 2004-12-27 | Shionogi & Co, Ltd. | Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| JP4523281B2 (ja) | 2002-01-17 | 2010-08-11 | メルク・シャープ・エンド・ドーム・コーポレイション | Hivインテグラーゼ阻害薬として有用なヒドロキシナフチリジノンカルボキサミド類 |
| JP3908248B2 (ja) * | 2002-08-13 | 2007-04-25 | 塩野義製薬株式会社 | Hivインテグラーゼ阻害活性を有するヘテロ環化合物 |
| EP1545538A2 (en) | 2002-08-29 | 2005-06-29 | Merck & Co., Inc. | N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| TW200505902A (en) * | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
| WO2005023189A2 (en) | 2003-09-03 | 2005-03-17 | Pharmacia Corporation | Method of cox-2 selective inhibitor and nitric oxide-donating agent |
| US7462721B2 (en) | 2003-09-19 | 2008-12-09 | Gilead Sciences, Inc. | Aza-quinolinol phosphonate integrase inhibitor compounds |
| ES2433477T3 (es) | 2004-02-11 | 2013-12-11 | Glaxosmithkline Llc | Inhibidores de integrasa de VIH |
-
2005
- 2005-02-10 ES ES05726489T patent/ES2433477T3/es not_active Expired - Lifetime
- 2005-02-10 EP EP05726489.7A patent/EP1720856B1/en not_active Expired - Lifetime
- 2005-02-10 CA CA002555176A patent/CA2555176A1/en not_active Abandoned
- 2005-02-10 KR KR1020067018565A patent/KR20070002006A/ko not_active Withdrawn
- 2005-02-10 RU RU2006128848/04A patent/RU2006128848A/ru not_active Application Discontinuation
- 2005-02-10 AU AU2005211733A patent/AU2005211733A1/en not_active Abandoned
- 2005-02-10 WO PCT/US2005/004085 patent/WO2005077050A2/en not_active Ceased
- 2005-02-10 US US10/597,902 patent/US8691991B2/en active Active
- 2005-02-10 BR BRPI0507628-5A patent/BRPI0507628A/pt not_active Application Discontinuation
- 2005-02-10 CN CNA2005800122898A patent/CN1976915A/zh active Pending
- 2005-02-10 JP JP2006553204A patent/JP4859676B2/ja not_active Expired - Lifetime
- 2005-02-10 MX MXPA06009132A patent/MXPA06009132A/es not_active Application Discontinuation
-
2006
- 2006-08-01 IL IL177189A patent/IL177189A0/en unknown
- 2006-08-11 MA MA29263A patent/MA28358A1/fr unknown
- 2006-09-05 NO NO20063958A patent/NO20063958L/no not_active Application Discontinuation
-
2014
- 2014-02-21 US US14/186,084 patent/US20140256713A1/en not_active Abandoned
-
2015
- 2015-04-27 US US14/696,784 patent/US20150225399A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2433477T3 (es) | 2013-12-11 |
| CA2555176A1 (en) | 2005-08-25 |
| BRPI0507628A (pt) | 2007-07-03 |
| JP2007523086A (ja) | 2007-08-16 |
| EP1720856A2 (en) | 2006-11-15 |
| MXPA06009132A (es) | 2007-03-26 |
| CN1976915A (zh) | 2007-06-06 |
| IL177189A0 (en) | 2006-12-10 |
| WO2005077050A2 (en) | 2005-08-25 |
| KR20070002006A (ko) | 2007-01-04 |
| MA28358A1 (fr) | 2006-12-01 |
| WO2005077050A3 (en) | 2006-11-23 |
| EP1720856A4 (en) | 2009-11-11 |
| US20150225399A1 (en) | 2015-08-13 |
| EP1720856B1 (en) | 2013-08-14 |
| RU2006128848A (ru) | 2008-03-20 |
| US20140256713A1 (en) | 2014-09-11 |
| US20070124152A1 (en) | 2007-05-31 |
| US8691991B2 (en) | 2014-04-08 |
| JP4859676B2 (ja) | 2012-01-25 |
| AU2005211733A1 (en) | 2005-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063958L (no) | HIV integrase inhibitorer | |
| CY1126771T1 (el) | Συνδυασμοι δολουτεγραβιρης και λαμιβουδινης για την αγωγη λοιμωξης απο hiv | |
| WO2005115398A3 (en) | Hiv integrase inhibitors | |
| CY1114981T1 (el) | Προφαρμακα ντολουτεγκραβιρης | |
| EA201000777A1 (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
| TW200738728A (en) | HIV integrase inhibitors | |
| NO20064547L (no) | Fremgangsmater for behandling av HIV infeksjon | |
| WO2008002959A3 (en) | Hiv integrase inhibitors | |
| UA89220C2 (ru) | Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы | |
| WO2004004657A3 (en) | Hiv integrase inhibitors | |
| NO20073105L (no) | Pyridazinonforbindelser | |
| NO20082135L (no) | HIV integrase inhibitorer | |
| NO20091955L (no) | Antivirale sammensetninger, og fremgangsmater for anvendelse | |
| NO20084749L (no) | Organiske forbindelser og deres anvendelser | |
| NO20083333L (no) | Fremgangsmater for forbedring av farmakokinetikken til HIV-integraseinhibitorer | |
| NO20090405L (no) | Ikke-nukleoside revers transcriptase inhibitorer | |
| WO2008118849A3 (en) | Hiv-1 protease inhibitors | |
| NO20090322L (no) | 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor | |
| NO20065075L (no) | Ikke-nukleosidbaserte revers-transkriptase-inhibitorer. | |
| WO2007019098A3 (en) | Hiv integrase inhibitors | |
| WO2007059125A3 (en) | Hiv integrase inhibitors | |
| WO2006081554A3 (en) | Phenyl-substituted pyrrolidones | |
| WO2020055858A8 (en) | Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication | |
| WO2004101512A3 (en) | Naphthyridine integrase inhibitors | |
| NO20080037L (no) | Kombinasjon av pyrimidylaminobenzamidforbindelser og imatinib for behandling eller forbyggelse av proliferative sykdommer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |